British start-up attacks London stock market as it reveals plan to delist
A British car battery company led by former Tesla executives has quit the London stock market less than a month after tapping investors for £500,000.
A British car battery company led by former Tesla executives has quit the London stock market less than a month after tapping investors for £500,000.
Here's why this tech investor thinks Intel has a lot of proving to do.
Sangamo Therapeutics' (SGMO) shares were sinking intraday Tuesday after the company said its partner
SiriusPoint Ltd (NYSE:SPNT) stock is trading higher on Tuesday after the specialty insurer and reinsurer announced the repurchase of all SiriusPoint common shares and warrants held by CM Bermuda Limited for $733 million. Following the closing of the repurchase transaction, CM Bermuda will have no remaining ownership interest in SiriusPoint and will cease to have any representation on, or observer rights with respect to, SiriusPoint’s board of directors. SiriusPoint will pay in two tranches, with
U.S. equities were closing out 2024 by edging lower at midday after opening the session higher.
Grid Dynamics Holdings, Inc. (GDYN) is joining the small-cap index on the back of AI, hyperscaler gains.
MicroAlgo, Inc. (NASDAQ:MLGO) shares are trading higher on Tuesday. The company disclosed the development of a quantum algorithm technology, featuring a FULL adder operation based on CPU registers in quantum gate computers. A FULL adder is a core component in classical digital circuits for binary addition, but its implementation in quantum computing is more intricate due to qubit properties like superposition and entanglement. MicroAlgo’s quantum algorithm efficiently executes FULL adder operati
Yum, Ralph Lauren upgraded: Wall Street's top analyst calls
Strategist Jim Paulsen says the economic backdrop is pointing to a slowdown in 2025 and this could drive down stocks.
The latest announcement is out from Inogen ( (INGN) ). Inogen, Inc. announced that it has received FDA 510(k) clearance for its Simeox 200 device, designed to enhance airway clearance and improve bronchial drainage for patients with chronic respiratory diseases. The clearance allows Inogen to expand its market reach in the U.S. and requires the company to make a $13 million milestone payment as part of a previous agreement. This development signifies a step forward in Inogen’s efforts to introdu